Vetter’s European clinical site receives permanent Manufacturer’s Authorization
11/09/2023
Join our experts for an in-depth look at how injectable drug owners can achieve right-first-time success with their clinical trial materials.
Ongoing investments in the supply chain for complex injectable medications
10/17/2023
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services
08/29/2023
After a complete revision of the EU GMP Annex 1, the final version was published in August 2022 and became effective just a few days ago on August 25,…
08/28/2023
Proven Process to Optimize Commercial Readiness
08/21/2023
We just published our annual sustainability report.
06/14/2023
John K. Moore, Vetter’s Director of Global Clinical Business Development, shares his biggest takeaways from the event.
06/13/2023
Vetter honored as an exceptionally managed company.
05/30/2023
Vetter further expands offerings for clinical development and manufacturing.
05/09/2023
03/31/2023
Vetter honored as winner in all six core award categories.
03/27/2023
